Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury

Circulation

Volumn 101, Issue 16, 2000, Pages 1990-1999

  Sehl, Patricia D ^a   Tai, Julie T N ^a   Hillan, Kenneth J ^a   Brown, Lesley A ^a   Goddard, Audrey ^a   Yang, Renhui ^a   Jin, Hongkui ^a   Lowe, David G ^a  

^a GENENTECH INC   (United States)

Author keywords

Genes; Molecular biology; Myocardial infarction

Indexed keywords

ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; COMPLEMENTARY DNA; CONNEXIN 40; ENDOTHELIN 1; FIBROBLAST GROWTH FACTOR; INTEGRIN; PHOSPHOLAMBAN; PLATELET DERIVED GROWTH FACTOR B; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P21; PROTEIN P53; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; GENE EXPRESSION REGULATION; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRESS; UNINDEXED SEQUENCE;

EID: 0034712693     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.16.1990     Document Type: Article

References (44)

1. Katz AM. Scientific insights from clinical studies of converting-enzyme inhibitors in the failing heart. Trends Cardiovasc Med. 1995;5:37-44.
2. Hunter J, Grace A, Chien K. Molecular and cellular biology of cardiac hypertrophy and failure. In: Chien Kenneth R, eds. Molecular Basis of Cardiovascular Disease: A Companion to Braunwald's Heart Disease. Philadelphia, Pa: WB Saunders Co; 1999:211-250.
3. Gidh-Jain M, Huang B, Jain P, Gick G, El-Sherif N. Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction. J Mol Cell Cardiol. 1998;30:627-637.
4. Calderone A, Takahashi N, Izzo NJ Jr, Thaik CM, Colucci WS. Pressure-and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 1995;92:2385-2390.
5. Buttrick P, Kaplan M, Leinwand L, Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cardiol. 1994;26:61-67.
6. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ Res. 1994; 75:23-32.
7. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 1991;5:3037-3046.
8. Boheler KR, Schwartz K. Gene expression in cardiac hypertrophy. Trends Cardiovasc Med. 1992;2:176-182.
9. Schoenfeld JR, Vasser M, Jhurani P, Ng P, Hunter JJ, Ross J Jr, Chien KR, Lowe DG. Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy. J Mol Cell Cardiol. 1998;30: 2269-2280.
10. Schena M, Shalon D, Davis R, Brown P. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270:467-470.
11. Heller R, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley D, Davis R. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci U S A. 1997;94: 2150-2155.
12. Iyer V, Elsen M, Ross D, Schuler G, Moore T, Lee J, Trent J, Staudt L, Hudson JJ, Boguski M, Lashkari D, Shalon D, Botstein D, Brown P. The transcriptional program in the response of human fibroblasts to serum. Science. 1999;283:83-87.
13. Geenen D, White T, Lampman R. Papillary mechanics and cardiac morphology of infarcted rat hearts after training. J Appl Physiol. 1987;63: 92-96.
14. Buttrick P, Perla C. Malhotra A, Geenen D, Lahorra M, Scheuer J. Effects of chronic dobutamine on cardiac mechanics and biochemistry after myocardial infarction in rats. Am J Physiol. 1991;260:H473-H479.
15. Kloner R, Kloner J. The effect of early exercise on myocardial infarct scar formation. Am Heart J. 1983;106:1009-1013.
16. Yang R, Bunting S, Gillett N, Clark R, Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation. 1995;92: 262-267.
17. Jin H, Yang R, Gillett N, Clark R, Ko A, Paoni N. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. J Cardiovasc Pharmacol. 1995;26:420-425.
18. Lashkari D, DeRisi J, McCusker J, Namath A, Gentile C, Hwang S, Brown P, Davis R. Yeast microarrays for genome wide parallel genetic and gene expression analysis. Proc Natl Acad Sci U S A. 1997;94: 13057-13062.
19. Shalon D, Smith S, Brown P. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 1996;6:639-645.
20. Hubank M, Schatz D. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 1994; 22:5640-5648.
21. Cheng S, Stoneking M. Complete mitochondrial genome amplification. Nat Genet. 1994;7:350-351.
22. Schena M, Shalon D, Heller R, Chai A, Brown P, Davis R. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A. 1996;93:10614-10619.
23. Shyjan A, de Sauvage F, Gillett N, Goeddel D, Lowe D. Molecular cloning of a retina-specific membrane guanylyl cyclase. Neuron. 1992; 9:727-737.
24. 33P-labeled riboprobes. Cell Vision. 1994;1:169-176.
25. Ruskoaho H. Atrial natriuretic peptides: Synthesis, release, and metabolism. Pharmacol Rev. 1992;44:479-602.
26. Cameron V, Aitken G, Ellmers I, Kennedy M, Espiner E. The sites of gene expression of atrial, brain and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology. 1996;137:817-824.
27. Lompré A, Mercadier J, Schwartz K. Changes in gene expression during cardiac growth. Int Rev Cytol. 1991;124:137-186.
28. Lee S, Wolfraim L, Wang E. Differential expression of S1 and elongation factor-1 alpha during rat development. J Biol Chem. 1993;268: 24453-244539.
29. Van Kempen M, Vermeulen J, Moorman A, Gros D, Paul D, Lamers W. Developmental changes of connexin40 and connexin43 mRNA distribution patterns in the rat heart. Cardiovasc Res. 1996;32:886-900.
30. Graf K, Do Y, Ashizawa N, Meehan W, Giachelli C, Marboe C, Fleck E, Hsueh W. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation. 1997;96:3063-3071.
31. Murphy A, Jones L II, Sims H, Strauss A. Molecular cloning of rat cardiac troponin I and analysis of troponin I isoform expression in developing rat heart. Biochemistry. 1991;30:707-712.
32. Benjamin I, Shelton J, Garry D, Richardson J. Temporospatial expression of the small HSP/alpha B-crystallin in cardiac and skeletal muscle during mouse development. Dev Dyn. 1997;208:75-84.
33. Muny C, Giachelli C, Schwartz S, Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol. 1994;145: 1450-1462.
34. Cleutjens J, Verluyten M, Smits J, Daemen M. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol. 1995;147:325-338.
35. Ulrich MM, Janssen AM, Daemen MJ, Rappaport L, Samuel JL, Contard F, Smits JF, Cleutjens JP. Increased expression of fibronectin isoforms after myocardial infarction in rats. J Mol Cell Cardiol. 1997;29: 2533-2543.
36. Hwang D, Dempsey A, Wang R-X, Rezvani M, Barrans J, Dai K-S, Wang H-Y, Ma H, Cukerman E, Liu Y-Q, Gu J-R. Zhang J-H, Tsui S, Waye M, Fung K-P, Lee C-Y, Liew C-C. A genome-based resource for molecular cardiovascular medicine. Circulation. 1997;96:4146-4203.
37. Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance. J Clin Invest. 1989;84:1693-1700.
38. Fishbein M, Maclean D, Maroko P. Experimental myocardial infarction in the rat. Am J Pathol. 1978;90:57-70.
39. Kryszke M, Vicart P. Regulation of the expression of the human vimentin gene: application to cellular immortalization. Pathol Biol (Paris). 1998; 46:39-45.
40. Welch M, DePace A, Verma S, Iwamatsu A, Mitchison T. The human Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin filament assembly. J Cell Biol. 1997;138:375-384.
41. Tsuchida K, Aihara H, Isogai K, Hanada K, Shibata N. Degradation of myocardial structural proteins in myocardial infarcted dogs is reduced by Ep459, a cysteine proteinase inhibitor. Biol Chem. 1986;367:39-45.
42. Palmer C, Scott B, Jones L. Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem. 1991; 266:11126-11130.
43. Schiaffino S, Samuel JL, Sassoon D. Lompré AM, Garner I, Marotte F, Buckingham M, Rappaport L, Schwartz K. Nonsynchronous accumulation of a-skeletal actin and b-myosin heavy chain mRNAs during early stages of pressure-overload-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res. 1989;64:937-948.
44. Black FM, Packer SE, Parker TG, Michael LH, Roberts R, Schwartz RJ, Schneider MD. The vascular smooth muscle α-actin gene is reactivated during cardiac hypertrophy provoked by load. J Clin Invest. 1991;88: 1581-1588.